Today Sponge Length Of Use Labeling Questioned By NDAC
This article was originally published in The Tan Sheet
Executive Summary
Inclusion of a package insert with each individual Today Sponge may more effectively communicate information about Allendale's contraceptive, Pittsburgh Poison Center Director Edward Krenzelok suggested at FDA's Nonprescription Drugs Advisory Committee meeting July 12.
You may also be interested in...
NDAC Veterans Join DSaRM Advisory Panel For DXM Safety Meeting
The presence of Nonprescription Drug Advisory Committee members as temporary voters on FDA's Drug Safety and Risk Management Advisory Committee brings expertise on OTC issues and a potential industry advocate to the Sept. 14 meeting on dextromethorphan abuse
NDAC Veterans Join DSaRM Advisory Panel For DXM Safety Meeting
The presence of Nonprescription Drug Advisory Committee members as temporary voters on FDA's Drug Safety and Risk Management Advisory Committee brings expertise on OTC issues and a potential industry advocate to the Sept. 14 meeting on dextromethorphan abuse
NDAC Veterans Join DSaRM Advisory Panel For DXM Safety Meeting
The presence of Nonprescription Drug Advisory Committee members as temporary voters on FDA's Drug Safety and Risk Management Advisory Committee brings expertise on OTC issues and a potential industry advocate to the Sept. 14 meeting on dextromethorphan abuse